Table 2.
Parameters | Total cohort (n=1003) | AF-HFpEF (n=387) | AF-HFmEF EF (n=150) | AF-HFrEF (n=466) | p level |
---|---|---|---|---|---|
CHF duration, months | 40 (12 : 96) | 48 (22.5 : 100) | 36 (12 : 72) | 48 (12 : 96) | 0.265 |
AF duration, months | 48 (15 : 96) | 50 (24 : 108) | 38 (12 : 89) | 40 (12 : 96) | 0.042 |
Age at AF debut | 62 (54.25 : 70.7) | 64.4 (57.9 : 72.6) | 60.8 (50.88 : 70.22) | 59.9 (51.5 : 68.55) | <0.0001 |
Age at HF debut | 62.1 (54.7 : 70.1) | 64 (57.5 : 72.9) | 61.65 (54.15 : 70.3) | 60.9 (52.9 : 67.8) | <0.0001 |
AF debuted after HF | 478 (47.7%) | 197 (50.9%) | 58 (38.7%) | 223 (47.9%) | 0.039 |
Type of AF | |||||
Paroxysmal | 276 (27.5%) | 144 (37.2%) | 30 (20%) | 102 (21.9%) | <0.001 |
Nonparoxysmal | 727 (72.5%) | 243 (62.8%) | 120 (80%) | 364 (78.1%) | |
Blood pressure | |||||
Systolic | 130 (120 : 140) | 140 (130 : 150) | 130 (120 : 140) | 120 (110 : 140) | <0.0001 |
Diastolic | 80 (70 : 90) | 80 (80 : 90) | 80 (70 : 90) | 80 (70 : 80) | 0.01 |
Heart rate | |||||
Rate (beats/min) | 84 (70 : 100) | 80 (68 : 90) | 85.5 (75.25 : 90.75) | 84 (75 : 97) | 0.226 |
Rate > 100, n (%) | 327 (32.6%) | 103 (26.6%) | 56 (37.3%) | 168 (36.1%) | 0.005 |
CHA2DS2-VASc score, Me (IQR) | 4 (3 : 5) | 5 (3 : 6) | 4 (3 : 5) | 4 (2 : 5) | <0.001 |
HAS-BLED, Me (IQR) | 3 (2 : 4) | 5 (3 : 6) | 4 (3 : 5) | 4 (2 : 5) | <0.001 |